Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa)

Published:2020-12 Issue: Volume:20 Page:100682
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Bacchieri Antonella,Rossi Andrea^ORCID,Morelli Paolo

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference12 articles.

1. Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005;Zwierzyna;BMJ,2018

2. Ethical Principles for Medical Research Involving Human Subjects;WMA Declaration of Helsinki,2020

3. EUPATI and patients in medicines research and development: guidance for patient involvement in ethical review of clinical trials;Klingmann,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical path activities in clinical trial setup and conduct: How to avoid bottlenecks and accelerate clinical trials;Drug Discovery Today;2023-10

2. Efficient Risk Mitigation Planning for a Clinical Trial;Therapeutic Innovation & Regulatory Science;2023-04-17

3. Efficient risk mitigation planning for a clinical trial;2022-11-03

4. Bioeconomy during the COVID-19 and perspectives for the post-pandemic world: Example from EU;EFB Bioeconomy Journal;2021-11

5. Responding to COVID-19 threats to trial conduct: lessons learned from a feasibility trial of a psychological intervention for South African adolescents;Trials;2021-07-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP